Antigen News and Research

RSS

ISCT expresses concern about companies offering unproven T-cell preservation services

ISCT, the International Society for Cell and Gene Therapy, the global professional society of clinicians, researchers, regulatory specialists, technologists and industry partners in the cell and gene therapy sector, today announces its objection to linking the benefits of cellular immunotherapy, in particular Chimeric Antigen Receptor (CAR) T-cell therapy, with recent market offerings for third party cryopreserving and banking of T-cells for future therapeutic use.

8 Aug 2019

Beckman Coulter Life Sciences publishes ClearLLab Control Cells white paper

Beckman Coulter Life Sciences has published a flow cytometry white paper to support the gating strategies behind its newly launched IVD ClearLLab Control Cells.

From Beckman Coulter Life Sciences - Flow Cytometry 6 Aug 2019

New blood test can detect clinically significant prostate cancer in high-risk patients

An international research team at Mahidol University in Bangkok, Thailand, has developed a new blood test capable of detecting clinically significant prostate cancer in high-risk patients, as reported in the medical journal Cancers on 27 July 2019.

6 Aug 2019

Research seeks to fight organ rejection in kidney transplant patients

While waiting on the transplant list, most patients are extremely sick and fighting just to stay alive.

1 Aug 2019

Adjuvant radiotherapy may help treat locally advanced prostate cancer

Some 5,400 men are diagnosed with prostate cancer in Finland every year. Although in most cases prostate cancer can be cured, approximately 900 men every year die of it.

30 Jul 2019

Defective immune signals could underlie some types of fatal heart disease

Researchers have come up with exciting evidence that confirms the role of abnormal immune signaling in myocarditis.

25 Jul 2019

New vaccine shows promise against toughest HIV strains

A new study reports successful immunization against a so-far invincible “death star” strain of an HIV-related laboratory virus (SIVmac239) and another tough strain. The new approach also achieves long-term protection with a single dose, showing that gene therapy could allow broad and durable protection, based on a modified form of the CD4 protein that allows HIV entry into human cells.

24 Jul 2019

CAR-T cells used to target glioblastoma

Immunotherapy is the new weapon against cancers and building upon existing research, a team of researchers from the Massachusetts General Hospital have devised a way to make immunotherapy more effective in a deadly and common form of brain cancer called glioblastoma.

24 Jul 2019

New technology helps develop more personalized treatments for patients with advanced cancers

Being able to identify targets for adoptive cell therapies is one of the first steps in developing personalized treatments for people with hard-to-treat cancers.

22 Jul 2019

Novel vaccine against bee sting allergy successfully tested

A recently completed trial on a bee sting vaccine containing a novel adjuvant called Advax to increase its efficacy has raised hopes that severe allergic reactions, sometimes fatal, to bee venom in allergic people could soon be a thing of the past. The vaccine was designed to neutralize the venom of the European honeybee.

17 Jul 2019

New study reveals 'clutch' proteins responsible for putting T cell activation 'into gear'

In collaborative research, scientists from three continents were able to discover a crucial bit of information about how T cells move proteins inside them to drive the immune response. This could help evolve specific new treatments centered on T cell selectivity.

12 Jul 2019

Nanotechnology-based compound used to deliver hepatitis B vaccine

Nanotechnology-based compounds are now being tested as a possible delivery vehicle for vaccines. A team of researchers demonstrated how the oral delivery vehicle SBA-15, one such nanotechnology-based compound can deliver an oral vaccine against hepatitis B to the immune system.

11 Jul 2019

Australia leads the world in childhood immunization coverage

Even as Australia reels under a deadly flu season, some solace may be found in the fact that almost 95% of of five-year-old Australian children are almost completely immunized against deadly childhood diseases, according to the latest report.

8 Jul 2019

Perspectives on how to communicate to older adults about stopping cancer screening

Over the past decades, the idea that all adults should get regularly screened for cancer -- with mammograms, colonoscopies and prostate specific antigen blood tests -- has been conveyed to the public time after time.

3 Jul 2019

$3.1 million NIH funding awarded to develop universal flu vaccine

In the race to create a universal flu vaccine not dependent on predicting strains of flu, the Virginia-Maryland College of Veterinary Medicine's Department of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources has been awarded a $3.1 million grant.

1 Jul 2019

Antigen News and Research

ISCT expresses concern about companies offering unproven T-cell preservation services

Beckman Coulter Life Sciences publishes ClearLLab Control Cells white paper

New blood test can detect clinically significant prostate cancer in high-risk patients

Research seeks to fight organ rejection in kidney transplant patients

Adjuvant radiotherapy may help treat locally advanced prostate cancer

Defective immune signals could underlie some types of fatal heart disease

New vaccine shows promise against toughest HIV strains

CAR-T cells used to target glioblastoma

New technology helps develop more personalized treatments for patients with advanced cancers

Novel vaccine against bee sting allergy successfully tested

New study reveals 'clutch' proteins responsible for putting T cell activation 'into gear'

Nanotechnology-based compound used to deliver hepatitis B vaccine

Australia leads the world in childhood immunization coverage

Perspectives on how to communicate to older adults about stopping cancer screening

$3.1 million NIH funding awarded to develop universal flu vaccine

Scientists reveal mechanism of tumor metastasis and tumor-suppressive role of UDP-glucose

New prostate cancer test could bring an end to unnecessary biopsies

New class of radiopharmaceuticals offer fresh perspective on cancer imaging, theranostics

Interim scan during therapy helps guide prostate cancer treatment, shows research

TEST-1 Using SPR to Confront the Antibody Reproducibility Crisis

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News